909
Views
46
CrossRef citations to date
0
Altmetric
Research Article

The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel

, , , , , , , , , , , , & show all
Pages 802-810 | Received 06 Sep 2012, Accepted 30 Nov 2012, Published online: 14 Feb 2013

References

  • HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002
  • Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005;192:989–97
  • Keshavarz M, Cheung NW, Babaee GR, et al. Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes. Diabetes Res Clin Pract 2005;69:279–86
  • Yang X, Hsu-Hage B, Zhang H, et al. Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes. Diabetes Care 2002;25:1619–24
  • Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773–9
  • Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000;49:2208–11
  • Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008;31:340–6
  • Jiwani A, Marseille E, Lohse N, et al. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 2012;25:600–10
  • Agarwal MM, Dhatt GS, Shah SM. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 2010;33:2018–20
  • Poncet B, Touzet S, Rocher L, et al. Cost-effectiveness analysis of gestational diabetes mellitus screening in France. Eur J Obstet Gynecol Reprod Biol 2002;103:122–9
  • Werner EF, Pettker CM, Zuckerwise L, et al. Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the diabetes and pregnancy study groups cost-effective? Diabetes care 2012;35:529–35
  • Drummond MF, O’Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications; 1997:305
  • Santos-Ayarzagoitia M, Salinas-Martinez AM, Villarreal-Perez JZ. Gestational diabetes: validity of ADA and WHO diagnostic criteria using NDDG as the reference test. Diabetes Res Clin Pract 2006;74:322–8
  • World Bank. World Development Report 1993: investing in health. New York (NY): Oxford University Press; 1993
  • Round JA, Jacklin P, Fraser RB, et al. Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman’s individual risk of disease. Diabetologia 2011;54:256–63
  • Culligan PJ, Myers JA, Goldberg RP, et al. Elective cesarean section to prevent anal incontinence and brachial plexus injuries associated with macrosomia–a decision analysis. Int Urogynecol J Pelvic Floor Dysfunct 2005;16:19–28; discussion 28
  • Horvath K, Koch K, Jeitler K, et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 2010;340:c1395
  • Siribaddana SH, Deshabandu R, Rajapakse D, et al. The prevalence of gestational diabetes in a Sri Lankan antenatal clinic. Ceylon Med J 1998;43:88–91
  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862–8
  • Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93:4774–9
  • World Health Organization. Life Tables for WHO Member States. 2012. Available from: http://www.who.int/healthinfo/statistics/mortality_life_tables/en/ [last accessed 29 Jan 2013]
  • Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England J Med 2002;346:393–403
  • Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289–97
  • Wendland EM, Duncan BB, Mengue SS, Schmidt MI. Lesser than diabetes hyperglycemia in pregnancy is related to perinatal mortality: a cohort study in Brazil. BMC Preg Childbirth 2011;11:92
  • Gonzalez JC, Walker JH, Einarson TR. Cost-of-illness study of type 2 diabetes mellitus in Colombia. Pan Am J Pub Health 2009;26:55–63
  • Caro JJ, Ward AJ, O'Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the US. Diabetes Care 2002;25:476–81
  • Dall TM, Mann SE, Zhang Y, et al. Distinguishing the economic costs associated with type 1 and type 2 diabetes. Popul Health Manag 2009;12:103–10
  • Gilmer TP, Roze S, Valentine WJ, et al. Cost-effectiveness of diabetes case management for low-income populations. Health Serv Res 2007;42:1943–59
  • Zhuo X, Zhang P, Hoerger T. Lifetime cost of type 2 diabetes in the US. Diabetes Pro – Professional Resources Online. Alexandria (VA): American Diabetes Association; 2010
  • Jonsson B. Revealing the cost of Type II diabetes in Europe. Diabetologia 2002;45:S5–12
  • Nolan JJ, O'Halloran D, McKenna TJ, et al. The cost of treating type 2 diabetes (CODEIRE). Irish Med J 2006;99:307–10
  • Bagust A, Hopkinson PK, Maier W, Currie CJ. An economic model of the long-term health care burden of Type II diabetes. Diabetologia 2001;44:2140–55
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837–53
  • Cameron CG, Bennett HA. Cost-effectiveness of insulin analogues for diabetes mellitus. CMAJ Journal Assoc Med Canadienne 2009;180:400–7
  • USRDS Coordinating Center. December 21. United States Renal Data System (USRDS). Available from: http://www.usrds.org/%3E [last accessed 21 December 2011]
  • Ashkenazy R, Abrahamson MJ. Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Internal Med 2006;21:386–92
  • World Health Organization. CHOosing Interventions that are Cost Effective (WHO-CHOICE): Cost-effectiveness thresholds. 2011. Available from: http://www.who.int/choice/costs/CER_thresholds/en/index.html [last accessed 29 Jan 2013]
  • Central Intelligence Agency. The World Fact Book. 2011. In COUNTRY COMPARISON: GDP - PER CAPITA (PPP). Available from: https://http://www.cia.gov/library/publications/the-world-factbook/rankorder/2004rank.html%3E [last accessed 9 July 2011]
  • Ramachandran K, van Wert J, Gopisetty G, Singal R. Developmentally regulated demethylase activity targeting the betaA-globin gene in primary avian erythroid cells. Biochemistry 2007;46:3416–22
  • Diabetes Prevention Program Research G. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003;26:2518–23
  • Ben-Haroush A, Glickman H, Yogev Y, et al. Induction of labor in pregnancies with suspected large-for-gestational-age fetuses and unfavorable cervix. Eur J Obstet Gynecol Reprod Biol 2004;116:182–5
  • World Health Organization. World Health Statistics 2011. Available from: http://www.who.int/whosis/whostat/2011/en/index.html [last accessed 29 Jan 2013]
  • Lauenborg J, Hansen T, Jensen DM, et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 2004;27:1194–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.